Exo Therapeutics

Building a new discovery paradigm to unlock intractable drug targets with exosites

[Exo Therapeutics @ExoTherapeutics]

🌍Happy Earth Day from Exo! Science has always taught us to respect nature, after all, it's where our greatest discoveries begin.
#EarthDay #Biotech #Sustainability #LifeSciences

[Exo Therapeutics @ExoTherapeutics]

Research in The EMBO Journal reveals that the cGAS-STING immune pathway drives premature aging caused by telomere shortening -- not just the short telomeres themselves.

Learn more: https://t.co/6JB0qyV7UX

[Exo Therapeutics @ExoTherapeutics]

Today is International Women's Day. This year's Give To Gain Campaign encourages a mindset of generosity and collaboration. Learn more: https://t.co/ocHVFdziKk
#IWD2026 #GiveToGain

[Exo Therapeutics @ExoTherapeutics]

Today is #RareDiseaseDay. At Exo, our lead preclinical program targeting the TBK1/STING interaction of the cGAS-STING pathway could potentially treat monogenic rare diseases including COPA, SAVI and Aicardi-Goutieres Syndrome.

[Exo Therapeutics @ExoTherapeutics]

Today marks the start of Biocom's Global Life Science Partnering & Investor Conference in La Jolla, California. Come join us and connect with Dorothy Lou Bailey and Alan Saghatelian, PhD! Reach out to [email protected] to schedule a meeting.

[Exo Therapeutics @ExoTherapeutics]

In March's Exo Explorations we look at a paper in Cell Biology which demonstrates a new link between Exo's work targeting the cGAS-STING pathway and aging. Learn more here: https://t.co/25ponlQz4f

[Exo Therapeutics @ExoTherapeutics]

This Black History Month, we’re shining a light on autoimmune conditions—which disproportionately affect Black communities and are often under diagnosed or misdiagnosed due to systemic bias in healthcare.

Learn how the community is uniquely impacted by Lupus.

[Exo Therapeutics @ExoTherapeutics]

Exo will be attending the Global Life Science Partnering & Investor Conference in La Jolla, California. Interested in connecting while there? Reach out to [email protected] to schedule a meeting.

[Exo Therapeutics @ExoTherapeutics]

Exo's program targeting the TBK1/STING interaction within the cGAS-STING pathway represents a first-in-class approach to target this pathway, inspiring new therapeutic approaches for several neurodegenerative diseases, including AD, Parkinson's and ALS.
https://t.co/V8yDf9PUnU

[Exo Therapeutics @ExoTherapeutics]

Happy Lunar New Year to all who celebrate! This year we are celebrating in spirit with our partners @pharmaron and are so grateful for our team in China.

[Exo Therapeutics @ExoTherapeutics]

Today Exo is honoring Martin Luther King, Jr. Day.

[Exo Therapeutics @ExoTherapeutics]

Happy holidays from the team at Exo!

[Exo Therapeutics @ExoTherapeutics]

Exo Explorations: Examining a TBK1-independent primordial function of STING in lysosomal biogenesis. Molecular Cell reveals a primordial function of STING in the biogenesis of lysosomes, essential organelles in immunity & cellular stress resistance. https://t.co/j3MCTVkZzS

[Exo Therapeutics @ExoTherapeutics]

This month's Exo Explorations examines the connection between TBK1 & Parkinson's.

A Journal of Nueroinflammation article shows activated TBK1 promotes ACSL1-mediated microglia lipid droplet accumulation & neuroinflammation in PD.

https://t.co/BVrPbsenUO

#Parkinsons #PD

[Exo Therapeutics @ExoTherapeutics]

Happy Thanksgiving from the Exo team!

[Exo Therapeutics @ExoTherapeutics]

Tomorrow is Aicardi-Goutieres Syndrome (AGS) Awareness Day.

#DYK Exo's target, the STING-TBK1 pathway has been implicated in AGS and other autoimmune disorders? Check out the AGS Advocacy Association to learn how you can get involved https://t.co/4FCM3EPZK2

[Exo Therapeutics @ExoTherapeutics]

Believe it or not, we're less than 2 months away from #JPMWeek26! Exo will be there, will you? Now is the time to think about your calendar for the week - reach out today to schedule a meeting with the Exo team at [email protected]. #JPM26 #biotech #JPMWeek2026

[Exo Therapeutics @ExoTherapeutics]

Happy National STEM Day! Today, we celebrate the power of Science, Technology, Engineering & Math to change the world.
At Exo, we are striving to create a new paradigm in medicine by unlocking intractable drug targets with exosites.

#NationalSTEMDay #WomenInSTEM #STEMCareers

[Exo Therapeutics @ExoTherapeutics]

November is Dermatology Awareness Month. Did you know Exo's target, the STING-TBK1 pathway, was recently implicated in dermatomyositis? Want to learn more about the pathway's implications in dermatomyositis? Read the paper here: https://t.co/xkcuc0hwIF

[Exo Therapeutics @ExoTherapeutics]

📍Are you in Chicago for American College of Rheumatology’s Convergence?

👋 Catch up with Exo's Dorothy Lou Bailey and Alexandra Joseph!

#ACR2025